InsiderFlow

Mark Chin

ELVN

Mark Chin serves as Director at Enliven Therapeutics, Inc. (ELVN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$8.00M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$8.00M

Companies Traded

1

ELVN

Active Period

Jul 2021

1 total trades

Most Recent

Buy ELVN

Jul 16, 2021 · $8.00M

Mark Chin's Insider Trading at Enliven Therapeutics, Inc. (ELVN)

Buys

1 · $8.00M

Sells

0 · $0.00

Total Shares Bought

1,333,333

Total Shares Sold

0

ELVN Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Jul 16, 2021Buy1,333,333$6.00$8.00M2,344,070